Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2012

01-08-2012 | Commentary

Comprehensive medication review: development of a collaborative procedure

Authors: Saija Leikola, Lea Tuomainen, Sirpa Peura, Antti Laurikainen, Alan Lyles, Eeva Savela, Marja Airaksinen

Published in: International Journal of Clinical Pharmacy | Issue 4/2012

Login to get access

Abstract

This commentary describes the development and evidence-base of the Comprehensive Medication Review (CMR) procedure for community and hospital settings in Finland. The development was coordinated by a national steering group. The group collaborated with 26 experienced pharmacists who developed and tested CMR procedures during a 1.5 year accreditation training for CMR. The development consisted of: (1) a literature review and inventory of medication review procedures in different countries; (2) the creation of potential procedures and related documentation; (3) integration of potential procedures into a national standard procedure; and (4) piloting the standard procedure in practice settings. The resulting comprehensive medication review procedure requires access to a patient’s clinical information, an inhome patient interview and a case conference with the collaborating physician. This procedure covers the four main dimensions critical for safe and appropriate geriatric pharmacotherapy: aging and safety; co-morbidities; polypharmacy; and adherence. The CMR measures and documentation build on these dimensions.
Literature
1.
go back to reference Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296:1858–66.PubMedCrossRef Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296:1858–66.PubMedCrossRef
2.
go back to reference Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a 5 year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151–8.PubMedCrossRef Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a 5 year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151–8.PubMedCrossRef
3.
go back to reference Cipolle R, Strand L, Morley P. Drug therapy problems. In: Pharmaceutical Care Practice. The Clinician’s Guide. 2nd ed. McGraw-Hill: NewYork; 2004. p. 171–200. ISBN: 0-07-136259-2. Cipolle R, Strand L, Morley P. Drug therapy problems. In: Pharmaceutical Care Practice. The Clinician’s Guide. 2nd ed. McGraw-Hill: NewYork; 2004. p. 171–200. ISBN: 0-07-136259-2.
4.
go back to reference Westerlund T, Almarsdóttir A, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21:245–50.PubMedCrossRef Westerlund T, Almarsdóttir A, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21:245–50.PubMedCrossRef
5.
go back to reference Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58:648–64.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58:648–64.PubMedCrossRef
6.
go back to reference American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2003;2008(48):341–53. American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2003;2008(48):341–53.
8.
go back to reference Leikola SN, Tuomainen L, Ovaskainen H, Peura S, Sevón-Vilkman N, Tanskanen P, et al. Continuing education course to attain collaborative comprehensive medication review competencies. Am J Pharm Educ. 2009;73:108.PubMedCrossRef Leikola SN, Tuomainen L, Ovaskainen H, Peura S, Sevón-Vilkman N, Tanskanen P, et al. Continuing education course to attain collaborative comprehensive medication review competencies. Am J Pharm Educ. 2009;73:108.PubMedCrossRef
9.
go back to reference Hakkarainen K. Models of pharmacists-conducted medication review—An international comparison. Master’s Thesis: University of Helsinki; 2008. Hakkarainen K. Models of pharmacists-conducted medication review—An international comparison. Master’s Thesis: University of Helsinki; 2008.
10.
go back to reference Kansanaho H, Puumalainen I, Varunki M, Ahonen R, Airaksinen M. Implementation of a professional program in Finnish community pharmacies in 2000–2002. Patient Educ Couns. 2005;57:272–9.PubMedCrossRef Kansanaho H, Puumalainen I, Varunki M, Ahonen R, Airaksinen M. Implementation of a professional program in Finnish community pharmacies in 2000–2002. Patient Educ Couns. 2005;57:272–9.PubMedCrossRef
12.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef
13.
go back to reference Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. Side effect rating scale. A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1–100.PubMedCrossRef Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. Side effect rating scale. A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1–100.PubMedCrossRef
15.
go back to reference Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24.PubMedCrossRef Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24.PubMedCrossRef
18.
go back to reference Cao YJ, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422–9.PubMedCrossRef Cao YJ, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422–9.PubMedCrossRef
19.
go back to reference Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther. 2006;31:485–91.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther. 2006;31:485–91.PubMedCrossRef
20.
go back to reference Yang JC, Tomlinson G, Naglie G. Medication lists for elderly patients: clinic-derived versus in-home inspection and interview. J Gen Intern Med. 2001;16:112–5.PubMedCrossRef Yang JC, Tomlinson G, Naglie G. Medication lists for elderly patients: clinic-derived versus in-home inspection and interview. J Gen Intern Med. 2001;16:112–5.PubMedCrossRef
Metadata
Title
Comprehensive medication review: development of a collaborative procedure
Authors
Saija Leikola
Lea Tuomainen
Sirpa Peura
Antti Laurikainen
Alan Lyles
Eeva Savela
Marja Airaksinen
Publication date
01-08-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9662-y

Other articles of this Issue 4/2012

International Journal of Clinical Pharmacy 4/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.